CLDF Title
Contact Us | Bookmark
HBV HE HCC HCV
About CLDF Centers of Educational Expertise  
Live CME Meetings Telewebs Webcasts Slide Library Abstract Library Conference Highlights
Featured Programs
HCV News Tonight   Banner2   EASL 2015   IC-Hep
 
             
  Liver News - REUTERS   Congress Calendar   Physician Resources  
 
 
New oral medication inhibits hepatitis D viral replication
07-29-2015
Elevated LFTS in celiac disease often normalize with gluten-free diet
07-28-2015
AbbVie gets FDA approval for Hep C combination therapy
07-24-2015
Evidence lacking for tests for psoriasis patients using biologic agents
07-23-2015
View Complete News Library
 
 
September 4-6
9th Annual ILCA (INTERNATIONAL LIVER CANCER ASSOCIATION) Conference
Paris, France
September 25-26
GALA Chicago Congress 2015
Chicago, IL
September 26-27
Gut Microbiome Conference 2015
Huntington Beach, CA
October 16-21
ACG 2015 Annual Scientific Meeting and Postgraduate Course
Honolulu, Hawaii
View all Congresses
 
HighwayRx
 
 
 
  Line  
  Featured Abstracts          
 
Modelling hepatitis C therapy-predicting effects of treatment
 
The promise of treatment as prevention for hepatitis C: Meeting the needs of people who inject drugs?
 
Cost-effectiveness of strategies for testing current hepatitis C virus infection
 
The effect of social functioning and living arrangement on treatment intent, specialist assessment and treatment uptake for hepatitis C virus infection among people with a history of injecting drug use: The ETHOS study
 
A phase II, randomized, controlled trial of S-adenosylmethionine in reducing serum alpha-fetoprotein (AFP) in patients with hepatitis C cirrhosis and elevated AFP
 
Restrictions for Medicaid Reimbursement of Sofosbuvir for the Treatment of Hepatitis C Virus Infection in the United States
 
 
Comparison of Accelerated and Standard Hepatitis B Vaccination Schedules in High-Risk Healthy Adults: A Meta-Analysis of Randomized Controlled Trials
 
A Treatment Algorithm for the Management of Chronic Hepatitis B Virus Infection in the United States: 2015 Update
 
Effects of long-term entecavir treatment on the incidence of hepatocellular carcinoma in chronic hepatitis B patients
 
Comparative Meta-Analysis of Tenofovir Disoproxil Fumarate versus Emtricitabine and Tenofovir Disoproxil Fumarate as Treatments for Patients with Chronic Hepatitis B
 
New Methods of Testing and Brain Imaging in Hepatic Encephalopathy: A Review
 
Varices and Variceal Hemorrhage in Cirrhosis. A new view of an old problem
 
 
The Clinical Relevance of Minimal Hepatic Encephalopathy - A Critical Look
 
Diagnosis of minimal hepatic encephalopathy
 
Systematic Review of Single Large and/or Multinodular Hepatocellular Carcinoma: Surgical Resection Improves Survival
 
Hepatic Re-resection Versus Transarterial Chemoembolization for the Treatment of Recurrent Hepatocellular Carcinoma after Initial Resection: a Systematic Review and Meta-analysis
 
Hepatocellular Carcinoma in the Absence of Cirrhosis in US Veterans is Associated with Non-Alcoholic Fatty Liver Disease
 
Impact of long-term tenofovir disoproxil fumarate on incidence of hepatocellular carcinoma in patients with chronic hepatitis B
 
 
          View All Abstracts  
  Line  
                 
 
HBV
Webcasts
Slide Library
Abstract Library
 
HE
Webcasts
Slide Library
Abstract Library
 
HCC
Slide Library
Abstract Library
 
 
HCV
Live CME Meetings
Telewebs
Webcasts
Slide Library
Abstract Library
 
CLDF Follow Us
   
 
About CLDF
Mission Statement
Board of Trustees
Board of Advisors
CLDF Supporters
 
Other Resources
Liver News Library
Journal Abstracts
Hep C Link to Care
 
Centers of
Educational Expertise
Regional Map
     
   
  The Chronic Liver Disease Foundation is a non-profit organization with content developed specifically for healthcare professionals.
© Copyright 2012-2015 Chronic Liver Disease Foundation. All rights reserved. This site is maintained as an educational resource for US healthcare providers only.
Use of this Web site is governed by the Chronic Liver Disease Foundation terms of use and privacy statement.